ArticleLeukemia2015
Common genetic variants in 11q13.3 and 9q22.33 are associated with molecular subgroups of multiple myeloma.
S W Erickson, O W Stephens, S S Chavan, E Tian, J Epstein, B Barlogie, C J Heuck, A J Vangsted
Abstract read
In one paragraphArticle in Leukemia, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
8 authors.
S W EricksonGenetic Epidemiology and Omics Research, Research Triangle Park, NC, USA.
O W StephensMyeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
S S ChavanMyeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
E TianMyeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
J EpsteinMyeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
B BarlogieMyeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
C J HeuckMyeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
A J VangstedDepartment of Hematology, Rigshospitalet, Copenhagen University, Copenhagen, Denmark.
Funding
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR029884 · NCRR · UNIV OF ARKANSAS FOR MED SCIS · PI LOWERY, CURTIS L · 2009 to 2011
$11.4MPredicting Chemotherapy-Induced Mucositis with Genetic and Clinical FactorsRC2NR011945 · NINR · UNIV OF ARKANSAS FOR MED SCIS · PI ANAISSIE, ELIAS J, COLEMAN, ELIZABETH ANN · 2009 to 2010
$1.3MNCRR NIH HHS 1UL1RR029884NCRR NIH HHS UL1 RR029884NINR NIH HHS 5RC2NR011945NINR NIH HHS RC2 NR011945
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Chromosomes, Human, Pair 11Chromosomes, Human, Pair 9Polymorphism, Single NucleotideCyclin D1Forkhead Transcription FactorsHumansMultiple MyelomaPhosphoric Diester HydrolasesCCND1 protein, humanCyclin D1Forkhead Transcription FactorsFOXE1 protein, humanPDE10A protein, humanPhosphoric Diester Hydrolases
Identifiers
PMID26308770
PMCPMC5330385
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390